2020
DOI: 10.1093/tas/txaa005
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the effect of tildipirosin administered alone or in combination with transdermal flunixin on the performance, health, activity, and well-being of transported feedlot calves on arrival at the feedlot

Abstract: Long distance transportation can be a significant source of stress to cattle and is associated with increased risk of bovine respiratory disease (BRD). The administration of a nonsteroidal anti-inflammatory drug (NSAID) has been shown to reduce stress following long distance transport. The objective of this study was to compare performance, health, accelerometer activity, and well-being between calves receiving either tildipirosin (Zuprevo 18%; Merck Animal Health, Madison, NJ) alone or in combination with tra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 17 publications
(21 reference statements)
0
8
0
Order By: Relevance
“…VAS scoring is a more subjective outcome but may be more sensitive to pain relative to CIS based on treatment differences being detected by VAS that were not detected with CIS. This may be due to CIS being designed to assess the severity of undifferentiated respiratory disease by signs of depression, lowered head, and ability to rise ( Perino and Apley, 1998 ), whereas the VAS used quantified depression, stance, head carriage, spinal alignment, movement, and ear carriage ( Martin et al, 2020 ) which may have captured more specific pain behaviors identified by Gleerup et al (2015) .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…VAS scoring is a more subjective outcome but may be more sensitive to pain relative to CIS based on treatment differences being detected by VAS that were not detected with CIS. This may be due to CIS being designed to assess the severity of undifferentiated respiratory disease by signs of depression, lowered head, and ability to rise ( Perino and Apley, 1998 ), whereas the VAS used quantified depression, stance, head carriage, spinal alignment, movement, and ear carriage ( Martin et al, 2020 ) which may have captured more specific pain behaviors identified by Gleerup et al (2015) .…”
Section: Discussionmentioning
confidence: 99%
“…A VAS score was assigned by two trained evaluators blinded to treatment allocations using methods adapted from Martin et al (2020) . The VAS used was a 100 mm (10 cm) line anchored at each end by descriptors of “No Pain” or “Severe Pain.” Seven parameters were used to assess pain: depression, tail swishing or flicking, stance, head carriage, spinal alignment, movement, and ear carriage also adapted from Martin et al (2020) . No pain was characterized by being alert and quick to show interest, no tail swishing, a normal stance, head carriage above spine level, a straight spine, moving freely around the pen and ears forward.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A total of 312 VAS scores made up the data set. As described in Martin et al (2020a) , a daily VAS pain assessment was conducted by two trained evaluators blinded to treatment allocations. The VAS used was a 100-mm (10 cm) line anchored by descriptors of “No Pain” on the left (0 cm) and “Severe Pain” on the right (10 cm).…”
Section: Methodsmentioning
confidence: 99%
“…The calculated doses of flunixin transdermal solution were based on actual BW measurements. A range of 3.21 to 3.84 mg/kg (mean 3.45 mg/kg) has been reported when the dosing chamber was used (Martin et al, 2020). To ensure that the solution was not accidentally removed during the disbudding procedures, placebo or transdermal flunixin meglumine was applied directly after disbudding.…”
Section: Experimental Design and Drug Administrationmentioning
confidence: 99%